Roivant Sciences Ltd. (NASDAQ: ROIV) set out its long-term vision on Tuesday during its Investor Day, outlining accelerated timelines and expanded commercial ambitions across several late-stage ...
We recently published 10 Easy Double-Digit Gainers. Roivant Sciences Ltd. (NASDAQ:ROIV) was one of the best performers last week. Roivant saw its share prices jump by 19.4 percent week-on-week, ...
Roivant financial position is robust, ending the quarter with $4.3 billion in cash and a management-asserted runway to ...
Biopharmaceutical company Roivant Sciences (NASDAQ:ROIV) reported earnings for the third quarter of 2024 on Monday, Feb. 10, that topped analysts' consensus estimates. Q3 revenue of $9.02 million ...
H.C. Wainwright analyst Douglas Tsao has maintained their bullish stance on ROIV stock, giving a Buy rating yesterday. Douglas Tsao has given his Buy rating due to a combination of factors including ...
Roivant Sciences Ltd. (NASDAQ:ROIV) ranks among the best stocks under $25 to buy now. Following the company’s analyst meeting on December 11, Leerink Partners boosted its price target for Roivant ...
Shares of Roivant Sciences (NASDAQ: ROIV) are soaring 11.4% higher as of 11:19 a.m. ET on Wednesday. The big gain came after Roivant and Priovant Therapeutics announced positive results from a ...
Stocktwits on MSN
ROIV stock nears record high: Moderna settlement drives Q4 profit, but pipeline catalysts keep retail interested
Roivant posted a net income of $355.7 million or $0.28 per share, compared to consensus estimates of a loss of $0.34, according to Fiscal.ai data. ・The bottom line was lifted by a $770.2 million gain ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
In May 2026, Roivant Sciences reported fourth-quarter 2026 results showing sales of US$2.52 million, a swing to quarterly net income of US$302.99 million, and full-year 2026 sales of US$8.26 million ...
Roivant Sciences stock performance snapshot Roivant Sciences (ROIV) has drawn investor attention recently after its share price closed at US$29.96, with total return around 9% over the past month and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results